Did you know drug abuse in the workplace costs employers approximately $81 billion annually by 70% of abusers that are employed? It is now even more important that employers provide a robust drug-testing program that offers employees alternative testing methods, especially during COVID.
For years, testing for drugs of abuse has been wrought by challenges encountered with urine laboratory-based testing. A number of these drawbacks include shy bladder issues, increased opportunity for dilution or adulteration, collection hassles, and of late, the ability to detect recent use in legalized marijuana states.
Laboratory-based oral fluid testing overcomes these issues! Oral fluid is easy to use, detects more positives and recent use, and allows for CDC-recommended 6 feet of separation.
OraSure Technologies is a leader in the development, manufacture, and distribution of oral fluid testing products for drugs of abuse, alcohol, and health and wellness testing. The Intercept® and OraSure® Oral Fluid Drug Tests offer laboratory confidence with oral fluid convenience. The Q.E.D® Saliva Alcohol Test and OralTox® Rapid Oral Fluid Drug Test offer instant results at the point of collection. The simple collection processes for these tests eliminate costs and dignity collection issues, reduce sample tampering while providing accurate results.
The company is bringing its expertise to the COVID-19 battle with a rapid antigen self-test and an oral fluid antibody test under development. In addition, its saliva collection devices are being used for the collection, both in at-home and professional settings, and transport of samples for COVID-19 molecular testing (PCR).